/

Empresas

Ec

No verificado

Eccogene

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa

16/03/2026

Industria

Biotecnología

Salud

Farmacéutica

Medicina - Varios

Cardiología

Eccogene Announces First Patient Enrolled in MIST Phase 2a Trial Evaluating ECC4703 as an Adjunct to Semaglutide for the Treatment of Obesity

Fuente

Editor

1.00

0

10/02/2026

Biotecnología

Farmacéutica

Sanidad

Salud

Fitness

Medicina - Varios

Industria

Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China

Fuente

Editor

1.00

0

16/12/2025

Industria

Ciencia

Cardiología

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Eccogene Announces First Patient Enrolled in MOSAIC Phase 2a Trial Evaluating ECC4703 and ECC0509, Individually and in Combination, for the Treatment of MASH

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0